{"component": "definition", "props": {"groups": [{"snippet_links": [], "size": 6, "samples": [{"hash": "25tl54bJL63", "uri": "/contracts/25tl54bJL63#rd-term", "label": "Master Collaboration and License Agreement", "score": 32.8346099854, "published": true}, {"hash": "5RZPiYInoI7", "uri": "/contracts/5RZPiYInoI7#rd-term", "label": "Master Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8542098999, "published": true}, {"hash": "8SXfpMngZh8", "uri": "/contracts/8SXfpMngZh8#rd-term", "label": "Master Collaboration and License Agreement (Moderna, Inc.)", "score": 29.8295688629, "published": true}], "snippet": "has the meaning set forth in Section 2.2(b).", "hash": "1ff20b11dc04f8372b7e9cbd9cce262e", "id": 1}, {"snippet_links": [{"key": "the-period", "type": "clause", "offset": [6, 16]}, {"key": "upon-the-effective-date", "type": "clause", "offset": [28, 51]}, {"key": "after-the-effective-date", "type": "clause", "offset": [100, 124]}, {"key": "change-of-control-of", "type": "definition", "offset": [136, 156]}, {"key": "either-party", "type": "definition", "offset": [157, 169]}], "size": 2, "samples": [{"hash": "kvl3fKbtviI", "uri": "/contracts/kvl3fKbtviI#rd-term", "label": "Option and License Agreement (Inhibrx, Inc.)", "score": 31.5708427429, "published": true}, {"hash": "2oarimkYnj9", "uri": "/contracts/2oarimkYnj9#rd-term", "label": "Option and License Agreement (Inhibrx, Inc.)", "score": 31.4832305908, "published": true}], "snippet": "means the period commencing upon the Effective Date and ending on the earlier of (i) five (5) years after the Effective Date, or (ii) a Change of Control of either Party.", "hash": "acfe474fc832633f88f4b2e1f8bde624", "id": 2}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-target", "type": "definition", "offset": [31, 46]}, {"key": "license-option-effective-date", "type": "definition", "offset": [76, 105]}, {"key": "cessation-of", "type": "clause", "offset": [194, 206]}, {"key": "ongoing-development-activities", "type": "clause", "offset": [211, 241]}, {"key": "related-obligations", "type": "definition", "offset": [249, 268]}, {"key": "clinical-supply", "type": "clause", "offset": [311, 326]}, {"key": "licensed-construct", "type": "definition", "offset": [334, 352]}, {"key": "licensed-product", "type": "clause", "offset": [356, 372]}, {"key": "directed-to", "type": "definition", "offset": [390, 401]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [434, 452]}, {"key": "termination-of-this-agreement-for", "type": "clause", "offset": [516, 549]}, {"key": "agreement-in-its-entirety", "type": "clause", "offset": [582, 607]}], "size": 2, "samples": [{"hash": "4lRvN4yNU1", "uri": "/contracts/4lRvN4yNU1#rd-term", "label": "Collaboration and License Option Agreement (ADARx Pharmaceuticals, Inc.)", "score": 37.6735112936, "published": true}, {"hash": "5P06dqp96JA", "uri": "/contracts/5P06dqp96JA#rd-term", "label": "Collaboration and License Option Agreement (ADARx Pharmaceuticals, Inc.)", "score": 37.5776865161, "published": true}], "snippet": "means, with respect to a given Licensed Target, the period beginning on the License Option Effective Date for such Licensed Target and ending on and expiring upon the earlier of (a) the date of cessation of any ongoing Development activities or any related obligations (including Manufacture of pre-clinical or clinical supply of any Licensed Construct or Licensed Product, in either case, Directed To such Licensed Target) performed by or on behalf of AbbVie for such Licensed Target, and (b) the effective date of termination of this Agreement for such Licensed Target or of this Agreement in its entirety.", "hash": "bd6ceddfaf5bec8c097cdc7154faa924", "id": 3}, {"snippet_links": [{"key": "period-from", "type": "definition", "offset": [10, 21]}, {"key": "license-commencement-date", "type": "definition", "offset": [26, 51]}, {"key": "the-parties", "type": "clause", "offset": [58, 69]}, {"key": "research-and-development-activities", "type": "clause", "offset": [102, 137]}, {"key": "the-applicable", "type": "clause", "offset": [153, 167]}, {"key": "rd-plan", "type": "clause", "offset": [168, 176]}, {"key": "unless-this-agreement", "type": "clause", "offset": [178, 199]}, {"key": "in-accordance-with", "type": "definition", "offset": [222, 240]}, {"key": "article-11", "type": "definition", "offset": [241, 251]}], "size": 2, "samples": [{"hash": "hs0FDpGclsz", "uri": "/contracts/hs0FDpGclsz#rd-term", "label": "Development, License and Supply Agreement (OS Therapies Inc)", "score": 34.2429847717, "published": true}, {"hash": "6ybGNzYd2NL", "uri": "/contracts/6ybGNzYd2NL#rd-term", "label": "Development, License and Supply Agreement (OS Therapies Inc)", "score": 34.1964416504, "published": true}], "snippet": "means the period from the License Commencement Date until the parties have completed their respective Research and Development activities as provided in the applicable R&D Plan, unless this Agreement is terminated earlier in accordance with Article 11.", "hash": "1d1f481a5fdb518ae1a20b80d572372e", "id": 4}, {"snippet_links": [{"key": "the-period", "type": "clause", "offset": [17, 27]}, {"key": "commencing-on-the-closing-date", "type": "clause", "offset": [28, 58]}], "size": 2, "samples": [{"hash": "iFmKO0zWVR", "uri": "/contracts/iFmKO0zWVR#rd-term", "label": "Subscription, Joint Development and Operating Agreement (Generex Biotechnology Corp)", "score": 18.0, "published": true}, {"hash": "5uSIajvslyS", "uri": "/contracts/5uSIajvslyS#rd-term", "label": "Subscription, Joint Development and Operating Agreement (Generex Biotechnology Corp)", "score": 18.0, "published": true}], "snippet": "means shall mean the period commencing on the Closing Date and ending on the 4th anniversary thereof.", "hash": "8c47bf532e59fe633fe5b168ed8e2e7b", "id": 5}, {"snippet_links": [{"key": "the-period", "type": "clause", "offset": [6, 16]}, {"key": "commencing-on", "type": "clause", "offset": [17, 30]}, {"key": "approval-by", "type": "clause", "offset": [112, 123]}, {"key": "in-the-territory", "type": "clause", "offset": [153, 169]}, {"key": "this-agreement", "type": "clause", "offset": [189, 203]}, {"key": "pursuant-to-the-terms", "type": "clause", "offset": [218, 239]}, {"key": "on-december", "type": "clause", "offset": [255, 266]}, {"key": "the-parties", "type": "clause", "offset": [299, 310]}, {"key": "mutually-agree", "type": "definition", "offset": [315, 329]}, {"key": "in-writing", "type": "definition", "offset": [330, 340]}], "size": 2, "samples": [{"hash": "knTWxextwJ0", "uri": "/contracts/knTWxextwJ0#rd-term", "label": "Collaborative Research, Development and License Agreement (Targacept Inc)", "score": 21.0, "published": true}], "snippet": "means the period commencing on January 1, 2001 and terminating on the earlier of: (a) the receipt of Regulatory Approval by \u2587\u2587. \u2587\u2587\u2587\u2587 in the last country in the Territory; (b) the date that this Agreement is terminated pursuant to the terms hereof; or (c) on December 31, 2008, or such later date as the Parties may mutually agree in writing.", "hash": "d8d4d8a8337b857a0817890854b92933", "id": 6}, {"snippet_links": [{"key": "the-period", "type": "clause", "offset": [6, 16]}, {"key": "commencing-on-the-closing-date", "type": "clause", "offset": [17, 47]}, {"key": "period-of", "type": "definition", "offset": [69, 78]}, {"key": "by-agreement", "type": "clause", "offset": [113, 125]}, {"key": "the-participants", "type": "clause", "offset": [129, 145]}], "size": 1, "samples": [{"hash": "5QmKEWuWIMF", "uri": "/contracts/5QmKEWuWIMF#rd-term", "label": "Subscription, Joint Development and Operating Agreement (Photogen Technologies Inc)", "score": 18.0, "published": true}], "snippet": "means the period commencing on the Closing Date and continuing for a period of [****] thereafter, or as extended by agreement of the Participants.", "hash": "4004094ee21b42204ecb6191fa8a2e51", "id": 7}, {"snippet_links": [{"key": "beginning-on-the-closing-date", "type": "clause", "offset": [17, 46]}, {"key": "second-anniversary", "type": "clause", "offset": [79, 97]}], "size": 1, "samples": [{"hash": "19aHL3ZaXnJ", "uri": "/contracts/19aHL3ZaXnJ#rd-term", "label": "Subscription, Joint Development and Operating Agreement (Safescience Inc)", "score": 18.0, "published": true}], "snippet": "means the period beginning on the Closing Date and ending on the date which is second anniversary thereof.", "hash": "a59d57c67941e29383e791508b1d0515", "id": 8}, {"snippet_links": [], "size": 1, "samples": [{"hash": "6bGg1rLuWSS", "uri": "/contracts/6bGg1rLuWSS#rd-term", "label": "Collaboration, Option and License Agreement (Exicure, Inc.)", "score": 32.882270813, "published": true}], "snippet": "means, on a Program-by-Program basis, the First R&D Term or the Second R&D Term, as applicable.", "hash": "2a311f909852adedf62f557bb1848303", "id": 9}, {"snippet_links": [], "size": 1, "samples": [{"hash": "kbkSbn7MwWZ", "uri": "/contracts/kbkSbn7MwWZ#rd-term", "label": "Reformulation and New Product Agreement (Cypress Bioscience Inc)", "score": 21.0, "published": true}], "snippet": "shall have the meaning set forth in Section 10.1.", "hash": "4548f47f6a08e4e4c55b0c05f17138d3", "id": 10}], "next_curs": "ClQSTmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjALEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIQcmQtdGVybSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "R&D Term", "size": 27, "snippet": "has the meaning set forth in Section 2.2(b).", "id": "rd-term", "examples": ["The JSC will cease to exist [***] after the end of the R&amp;D Term, provided that during the Post R&amp;D Period, the JSC shall be maintained to oversee any ongoing activities but it shall meet on ad hoc basis to govern activities as specified in Section 2.14.", "Absent further agreement of the Parties but subject to Section 2.8(c) for an applicable R&amp;D Program, the maximum duration of the R&amp;D Term is four (4) years, and all R&amp;D Programs will terminate upon expiration of the R&amp;D Term.", "Subject to and in accordance with the terms of this Agreement, during the R&amp;D Term the Parties will [***] undertake Development activities as set forth in R&amp;D Plans with the goal of identifying and Developing Collaboration mRNA Constructs and Product Candidates directed to R&amp;D Program Pathogens, [***] the \u201cR&amp;D Programs\u201d) and (c) [***].", "Subject to [***], during the R&amp;D Term, Moderna will not, and will cause each of its Affiliates not to, either itself, or together with any Third Party, [***].", "Each Party will furnish to the JSC a summary written report within [***] after each [***] and [***] occurring during the R&amp;D Term, describing its progress under the R&amp;D Plans and [***] as part of the Collaboration Activities during the previous [***] period.", "Furthermore, during the R&amp;D Term, Merck at its sole discretion may add or remove any Merck Exclusive Target as an R&amp;D Target of an established R&amp;D Program by providing written notice to Moderna.", "Following the expiration of the R&amp;D Term there will be a Post-R&amp;D Period during which Merck may define up to five (5) Target Product Profiles for which Merck may Develop [***] Product Candidates incorporating Collaboration mRNA Constructs from the Product Candidate Pool for such Target Product Profiles.", "Merck may exercise such right by providing written notice to Moderna at [***] prior to the expiration of the Initial R&amp;D Term and, subject to [***], the R&amp;D Extension Term will automatically go into effect.", "At the expiration of the R&amp;D Term, (i) all R&amp;D Programs will become \u201cDiscontinued Programs\u201d (ii) all R&amp;D Targets and R&amp;D [***] Targets that are not Locked Targets will become Discontinued Targets and (iii) all Collaboration mRNA Constructs that are not in a Product Candidate Pool will become Discontinued mRNA Constructs.", "For the avoidance of doubt, upon the expiration of the R&amp;D Term, [***]."], "related": [["collaboration-term", "Collaboration Term", "Collaboration Term"], ["research-term", "Research Term", "Research Term"], ["research-period", "Research Period", "Research Period"], ["research-program-term", "Research Program Term", "Research Program Term"], ["initial-term", "Initial Term", "Initial Term"]], "related_snippets": [], "updated": "2026-09-07T06:43:13+00:00"}, "json": true, "cursor": ""}}